Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study

This publication has 18 references indexed in Scilit:

• 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions
  European Journal Of Cancer, 1997
• The treatment of advanced neuroblastoma. Results of the spanish neuroblastoma study group (SNSG) studies
  European Journal Of Cancer, 1995
• Autologous Transplantation with Peripheral Blood Stem Cells in Children and Young Adults After Myeloablative Treatment: Nonrandomized Comparison Between GM-CSF and G-CSF for Mobilization
  Journal of Hematotherapy, 1995
• Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study
  British Journal of Cancer, 1993
• Prognostic Factors in Metastatic Neuroblastoma
  Journal of Pediatric Hematology/Oncology, 1992
• A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a
  Cancer Immunology, Immunotherapy, 1992
• High-dose melphalan with 6-hydroxydopamine–purged autologous bone marrow transplantation for poor-risk neuroblastoma
  Cancer, 1991
• Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: Results of the German neuroblastoma trial
  Medical and Pediatric Oncology, 1991
• The role of chemotherapy in the treatment of children with neuroblastoma stage IV: The GPO (German Pediatric Oncology Society) experience
  Klinische Padiatrie, 1990
• [131I]-Metaiodobenzylguanidine in the treatment of metastatic neuroblastoma
  Cancer Chemotherapy and Pharmacology, 1989